Compare YHGJ & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YHGJ | BRTX |
|---|---|---|
| Founded | 1975 | 1997 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Specialty Chemicals | Managed Health Care |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 5.4M |
| IPO Year | 2006 | 2015 |
| Metric | YHGJ | BRTX |
|---|---|---|
| Price | $2.92 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.4K | ★ 267.1K |
| Earning Date | 05-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,705,000.00 | $81,000.00 |
| Revenue This Year | N/A | $298.39 |
| Revenue Next Year | N/A | $64.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $0.50 | $0.16 |
| 52 Week High | $10.29 | $1.86 |
| Indicator | YHGJ | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 33.46 |
| Support Level | $2.61 | $0.19 |
| Resistance Level | $3.11 | $0.24 |
| Average True Range (ATR) | 0.18 | 0.02 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 9.64 | 7.69 |
Yunhong Green CTI Ltd develops, produces, distributes, and sells consumer products in the United States and several other countries, and manufactures film products for commercial and industrial use in the United States. The Company focuses on flexible film technologies and has developed products utilizing flexible films, including novelty balloons, pouches, and films for packaging applications. Its principal product lines include foil and latex balloons and related gift items, and flexible films for food and other packaging uses. It also assembles balloon-inspired gift items, including small gift bouquets with ribbons and/or a foil balloon, and holds patents related to flexible films, including films, zipper closures, valves, and other features.
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.